578 related articles for article (PubMed ID: 25778336)
21. Central venous catheter-related complications in acute myeloid
leukemia patients.
Khalil MO; Pierson N; Maymani H; Holter J; Cherry M
J Vasc Access; 2014; 15(6):543. PubMed ID: 24811602
[No Abstract] [Full Text] [Related]
22. Innominate vein stenosis in breast cancer patients after totally implantable venous access port placement.
Song MG; Seo TS; Kang EY; Yong HS; Seo JH; Choi YY
J Vasc Access; 2015; 16(4):315-20. PubMed ID: 25953212
[TBL] [Abstract][Full Text] [Related]
23. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
Goossens GA; Stas M; Moons P
Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
[TBL] [Abstract][Full Text] [Related]
24. Retained embolized fragment of totally implantable central venous catheter in right ventricle: it is really necessary to remove?
Tazzioli G; Gargaglia E; Vecchioni I; Papi S; Di Blasio P; Rossi R
J Vasc Access; 2015; 16(5):431-3. PubMed ID: 26109543
[TBL] [Abstract][Full Text] [Related]
25. Totally implantable central venous access ports. Analysis of 700 cases.
Barbetakis N; Asteriou C; Kleontas A; Tsilikas C
J Surg Oncol; 2011 Nov; 104(6):654-6. PubMed ID: 21671465
[TBL] [Abstract][Full Text] [Related]
26. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
[TBL] [Abstract][Full Text] [Related]
27. [Complications with totally implantable venous access device. A retrospective of 116 cases].
Talfer S; Conessa C; Hervé S; Roguet E; de Rotalier P; Poncet JL
Presse Med; 2003 Aug; 32(27):1263-8. PubMed ID: 14506448
[TBL] [Abstract][Full Text] [Related]
28. Totally implantable central venous catheters of the port-a-cath type: complications due to its use in the treatment of cancer patients.
Granic M; Zdravkovic D; Krstajic S; Kostic S; Simic A; Sarac M; Ivanovic N; Radovanovic D; Dikic S; Kovcin V
J BUON; 2014; 19(3):842-6. PubMed ID: 25261677
[TBL] [Abstract][Full Text] [Related]
29. Totally implantable venous access devices: The supraclavicular percutaneous approach and early complications.
Bai XM; Wang J; Zhou Y; Sun XW; Cheng L; Gu XS; Yuan Q; Jing J; Zhang J; Gu LY; Jin Y
J Cancer Res Ther; 2020; 16(7):1575-1581. PubMed ID: 33565502
[TBL] [Abstract][Full Text] [Related]
30. Totally implantable venous access devices in children with medical complexity: preliminary data from a tertiary care hospital.
Geremia C; De Ioris MA; Crocoli A; Adorisio O; Scrocca R; Lombardi MH; Staccioli S; Stella P; Amendola P; Ciliento G; De Peppo F; Campana A
J Vasc Access; 2017 Sep; 18(5):426-429. PubMed ID: 28574141
[TBL] [Abstract][Full Text] [Related]
31. Follow-up of radiologically totally implanted central venous access ports of the upper arm: long-term complications in 127,750 catheter-days.
Busch JD; Herrmann J; Heller F; Derlin T; Koops A; Adam G; Habermann CR
AJR Am J Roentgenol; 2012 Aug; 199(2):447-52. PubMed ID: 22826411
[TBL] [Abstract][Full Text] [Related]
32. Direct translumbar inferior vena cava ports for long-term central venous access in patients with cancer.
Butros SR; Walker TG; Salazar GM; Kalva SP; Oklu R; Wicky S; Ganguli S
J Vasc Interv Radiol; 2014 Apr; 25(4):556-60. PubMed ID: 24507994
[TBL] [Abstract][Full Text] [Related]
33. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
Subramaniam A; Kim KH; Bryant SA; Kimball KJ; Huh WK; Straughn JM; Estes JM; Alvarez RD
Gynecol Oncol; 2011 Oct; 123(1):54-7. PubMed ID: 21742372
[TBL] [Abstract][Full Text] [Related]
34. Using tunneled femoral vein catheters for "urgent start" dialysis patients: a preliminary report.
Hingwala J; Bhola C; Lok CE
J Vasc Access; 2014; 15 Suppl 7():S101-8. PubMed ID: 24817465
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of valved and nonvalved fully implantable catheters inserted via ultrasound-guided puncture for chemotherapy.
Zottele Bomfim GA; Wolosker N; Yazbek G; Bernardi CV; Valentim LA; De Castro TM; Pignataro BS; Benitti DA; Nishinari K
Ann Vasc Surg; 2014 Feb; 28(2):351-7. PubMed ID: 24094470
[TBL] [Abstract][Full Text] [Related]
36. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
Bassi KK; Giri AK; Pattanayak M; Abraham SW; Pandey KK
Indian J Cancer; 2012; 49(1):114-8. PubMed ID: 22842178
[TBL] [Abstract][Full Text] [Related]
37. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
Ghayyda SN; Roland D; Cade A
J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
[TBL] [Abstract][Full Text] [Related]
38. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
[TBL] [Abstract][Full Text] [Related]
39. Effect of catheter diameter on left innominate vein in breast cancer patients after totally implantable venous access port placement.
Song MG; Seo TS; Kim YH; Cho SB; Chung HH; Lee SH; Jung E
J Vasc Access; 2018 Nov; 19(6):615-619. PubMed ID: 29560786
[TBL] [Abstract][Full Text] [Related]
40. Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report.
Solinas G; Platini F; Trivellato M; Rigo C; Alabiso O; Galetto AS
J Vasc Access; 2017 Jul; 18(4):325-327. PubMed ID: 28665463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
